-
DiDi Advances Robotaxi Operations in China with New R2 Vehicle and Expanded Safety Infrastructure
-
Smart Car Seats Tested: Do Sensors and Apps Actually Improve Safety?
-
XPENG Launches Two New Models in UK; Pony.ai Robotaxi Enters Pilot
-
MedMira Receives U.S. FDA Breakthrough Device Designation for Its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
-
Pivotree Announces Third Quarter 2026 Results
-
Ur-Energy Commences Baseline Study Fieldwork; Nears Completion of Technical Report at Lost Soldier Uranium Project, Wyoming
-
ImageWorks Display Advances Whole-Store Solutions with a Re-Imagined Planniq Strong and Planniq Chill
-
Razavi Law Group Partners with Chapman University to Prepare the Next Generation of Attorneys
-
Broad Clinical Labs Drives Strong Digital Engagement by Connecting Customers with Published Research Through Bioz
-
PRAAMS AI Co-Investor Now Covers 400,000+ Global Instruments, With Responses From 3 Seconds, Cost From US$0.01, and Scalability to Millions of Users
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 17
-
Driving Global Innovation - GTDC Summit APJ Underscores Distribution's Transformative Power
-
Pilot-Founded Solara Global Jet Offers Charter, Leases and Air Cargo Nationwide and Overseas
-
How to Turn Your Garage into Usable Living Space
-
Three Inaugural CombatX Champions Crowned at BRAVE CF Road to BRAVE Event in Hungary
-
French Economy Shrinks 0.1% as Consumer Confidence Slumps
-
China's Factory Activity Contracts as Export Orders Weaken
-
Wall Street Ends Turbulent Week Higher Despite Inflation and AI Jitters
-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Luxury Skincare Brand Faces Backlash Over Futurist Manifesto Aesthetic
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Godzilla Minus Zero Review: Takashi Yamazaki’s Anti-Nuclear Allegory
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
DA Demands No-Work-No-Pay for Striking Municipal Workers in Coalition Talks
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
French health experts speak out against bee-killing pesticide
French health experts and patient associations on Tuesday urged authorities to protect the public from a bee-killing pesticide, saying the chemical could also harm children and adults.
The legislation to reintroduce in France acetamiprid, a pesticide that is harmful to ecosystems but popular with many farmers in Europe, was adopted on July 8, but without a proper debate to bypass gridlock in a divided parliament.
The move sparked anger in France, and support for a student-initiated petition against the legislation has snowballed, with university lecturers, left-wing lawmakers and star chefs backing it.
The petition had garnered more than 2 million signatures by Tuesday.
Health experts and patient associations have now weighed in, saying in an open letter in French daily Le Monde that they cannot back "a law that is dangerous to the health of our fellow citizens".
President Emmanuel Macron, who has been under increasing pressure to act, said he is waiting to hear the verdict of the Constitutional Council, which is expected to rule on the constitutionality of the law on August 7.
The health experts and patient associations urged the Constitutional Council to reject the legislation, calling on its members to "respond to the democratic demand strongly expressed by French citizens".
The signatories included Agnes Linglart, president of the French Paediatric Society, Olivier Coutard, president of the scientific council of France's flagship scientific research centre CNRS and Gerard Socie, president of the scientific council of the National Cancer Institute.
The Constitutional Council, the letter said, must protect future generations from the legislation that "without a shadow of reasonable doubt compromises the health of young people, children and the unborn".
The letter said the Senate committee preparing the bill heard from agricultural unions and government agencies but not "doctors, toxicologists or epidemiologists".
The senators did not consult representatives of the CNRS, health and labour ministries, even though occupational exposure to pesticides is a risk factor for humans, the letter said.
Citing the INSERM health and medical research organisation, the letter pointed to evidence of a link between exposure to pesticides and the occurrence of cancers, neurodegenerative, pulmonary and hormone-related disorders.
Banned in France since 2018, the chemical remains legal in the European Union.
Ch.P.Lewis--AT